- Home
- XNCR vs SDHC Comparison
XNCR vs SDHC Comparison
Compare XNCR & SDHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- SDHC
- Stock Information
- Founded
- XNCR 1997
- SDHC 2008
- Country
- XNCR United States
- SDHC United States
- Employees
- XNCR N/A
- SDHC N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- SDHC
- Sector
- XNCR Health Care
- SDHC
- Exchange
- XNCR Nasdaq
- SDHC Nasdaq
- Market Cap
- XNCR 1.7B
- SDHC 1.5B
- IPO Year
- XNCR 2013
- SDHC 2024
- Fundamental
- Price
- XNCR $24.20
- SDHC $27.95
- Analyst Decision
- XNCR Strong Buy
- SDHC Hold
- Analyst Count
- XNCR 9
- SDHC 6
- Target Price
- XNCR $36.33
- SDHC $32.80
- AVG Volume (30 Days)
- XNCR 850.2K
- SDHC 83.8K
- Earning Date
- XNCR 11-06-2024
- SDHC 12-31-2024
- Dividend Yield
- XNCR N/A
- SDHC N/A
- EPS Growth
- XNCR N/A
- SDHC N/A
- EPS
- XNCR N/A
- SDHC 4.71
- Revenue
- XNCR $85,164,000.00
- SDHC $905,304,000.00
- Revenue This Year
- XNCR N/A
- SDHC $27.04
- Revenue Next Year
- XNCR $89.22
- SDHC $14.68
- P/E Ratio
- XNCR N/A
- SDHC $5.91
- Revenue Growth
- XNCR N/A
- SDHC 17.46
- 52 Week Low
- XNCR $15.31
- SDHC $20.55
- 52 Week High
- XNCR $27.24
- SDHC $39.50
- Technical
- Relative Strength Index (RSI)
- XNCR 44.92
- SDHC 29.17
- Support Level
- XNCR $22.74
- SDHC $31.04
- Resistance Level
- XNCR $25.54
- SDHC $33.02
- Average True Range (ATR)
- XNCR 1.17
- SDHC 1.21
- MACD
- XNCR -0.33
- SDHC -0.44
- Stochastic Oscillator
- XNCR 22.00
- SDHC 7.81
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
About SDHC Smith Douglas Homes Corp.
Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. The company has organized into five geographical segments so their reportable segments include Atlanta, Raleigh, Charlotte, Nashville, and Alabama which consists of both Birmingham and Huntsville.